Nucleic Acid Therapeutics: Concepts for Targeted Delivery to Solid Tumors

• Hanahan D , WeinbergRA. The hallmarks of cancer. Cell100(1), 57–70 (2000).
   PubMed Web of Science ®Google Scholar
• Folkman J . Role of angiogenesis in tumor growth and metastasis. Semin. Oncol.29(6 Suppl. 16), 15–18 (2002).
   PubMed Web of Science ®Google Scholar
• Apostolopoulos C , CastellanoL, StebbingJ, GiamasG. Bendamustine as a model for the activity of alkylating agents. Future Oncol.4(3), 323–332 (2008).
   PubMed Web of Science ®Google Scholar
• Longley DB , HarkinDP, JohnstonPG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer3(5), 330–338 (2003).
   PubMed Web of Science ®Google Scholar
• Gascoigne KE , TaylorSS. How do anti-mitotic drugs kill cancer cells? J. Cell. Sci.122(15), 2579–2585 (2009).
   PubMed Web of Science ®Google Scholar
• Baguley BC . Multidrug resistance in cancer. Methods Mol. Biol.596, 1–14 (2009).
   Google Scholar
• Drablos F , FeyziE, AasPAet al. Alkylation damage in DNA and RNA-repair mechanisms and medical significance. DNA Repair (Amst.) 3(11), 1389–1407 (2004).
   PubMed Web of Science ®Google Scholar
• Klein S , McCormickF, LevitzkiA. Killing time for cancer cells. Nat. Rev. Cancer5(7), 573–580 (2005).
   PubMed Web of Science ®Google Scholar
• Riely GJ . Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. J. Thorac. Oncol.3(6 Suppl. 2), S146–S149 (2008).
   PubMed Web of Science ®Google Scholar
• Klein S , LevitzkiA. Targeting the EGFR and the PKB pathway in cancer. Curr. Opin. Cell Biol.21(2), 185–193 (2009).
   PubMed Web of Science ®Google Scholar
• Iyer AK , KhaledG, FangJ, MaedaH. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today11(17–18), 812–818 (2006).
   PubMed Web of Science ®Google Scholar
• Torchilin VP . Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J.9(2), E128–E147 (2007).
   PubMed Web of Science ®Google Scholar
• Hilger RA , RichlyH, GrubertMet al. Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil. Int. J. Clin. Pharmacol. Ther. 43(12), 588–589 (2005).
   PubMedGoogle Scholar
• Twelves CJ , DobbsNA, AldhousM, HarperPG, RubensRD, RichardsMA. Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer. Cancer Chemother. Pharmacol.28(4), 302–307 (1991).
   PubMed Web of Science ®Google Scholar
• Verschraegen CF , SkubitzK, DaudAet al. A Phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 63(5), 903–910 (2009).
   PubMed Web of Science ®Google Scholar
• Aghi M , HochbergF, BreakefieldXO. Prodrug activation enzymes in cancer gene therapy. J. Gene Med.2(3), 148–164 (2000).
   PubMed Web of Science ®Google Scholar
• Lo HW , DayCP, HungMC. Cancer-specific gene therapy. Adv. Genet.54, 235–255 (2005).
   PubMed Web of Science ®Google Scholar
• Kelly EJ , RussellSJ. MicroRNAs and the regulation of vector tropism. Mol. Ther.17(3), 409–416 (2009).
   PubMed Web of Science ®Google Scholar
• Sahu NK , ShilakariG, NayakA, KohliDV. Antisense technology: a selective tool for gene expression regulation and gene targeting. Curr. Pharm. Biotechnol.8(5), 291–304 (2007).
   PubMed Web of Science ®Google Scholar
• Kang MH , ReynoldsCP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin. Cancer Res.15(4), 1126–1132 (2009).
   PubMed Web of Science ®Google Scholar
• Fire A , XuS, MontgomeryMK, KostasSA, DriverSE, MelloCC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature391(6669), 806–811 (1998).
   PubMed Web of Science ®Google Scholar
• Leung RK , WhittakerPA. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol. Ther.107(2), 222–239 (2005).
   PubMed Web of Science ®Google Scholar
• Whitehead KA , LangerR, AndersonDG. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov.8(2), 129–138 (2009).
   PubMed Web of Science ®Google Scholar
• Tiemann K , RossiJJ. RNAi-based therapeutics – current status, challenges and prospects. EMBO Mol. Med.1(3), 142–151 (2009).
   PubMed Web of Science ®Google Scholar
• Kaur H , BabuBR, MaitiS. Perspectives on chemistry and therapeutic applications of locked nucleic acid (LNA). Chem. Rev.107(11), 4672–4697 (2007).
   PubMed Web of Science ®Google Scholar
• Plank C , ZaunerW, WagnerE. Application of membrane-active peptides for drug and gene delivery across cellular membranes. Adv. Drug Deliv. Rev.34(1), 21–35 (1998).
   PubMed Web of Science ®Google Scholar
• Blaese RM , CulverKW, MillerADet al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270(5235), 475–480 (1995).
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M , Hacein-BeyS, De Saint BG et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science288(5466), 669–672 (2000).
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S , GarrigueA, WangGPet al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118(9), 3132–3142 (2008).
   PubMed Web of Science ®Google Scholar
• Ehrhardt A , HaaseR, SchepersA, DeutschMJ, LippsHJ, BaikerA. Episomal vectors for gene therapy. Curr. Gene Ther.8(3), 147–161 (2008).
   PubMed Web of Science ®Google Scholar
• Ivics Z , IzsvakZ. Transposons for gene therapy! Curr. Gene Ther.6(5), 593–607 (2006).
   PubMed Web of Science ®Google Scholar
• Freimuth P , PhilipsonL, CarsonSD. The coxsackievirus and adenovirus receptor. Curr. Top. Microbiol. Immunol.323, 67–87 (2008).
   PubMed Web of Science ®Google Scholar
• Raper SE , YudkoffM, ChirmuleNet al. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum. Gene Ther. 13(1), 163–175 (2002).
   PubMed Web of Science ®Google Scholar
• Everts M , CurielDT. Transductional targeting of adenoviral cancer gene therapy. Curr. Gene Ther.4(3), 337–346 (2004).
   PubMed Web of Science ®Google Scholar
• Kreppel F , GackowskiJ, SchmidtE, KochanekS. Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors. Mol. Ther.12(1), 107–117 (2005).
   PubMed Web of Science ®Google Scholar
• Kreppel F , KochanekS. Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide. Mol. Ther.16(1), 16–29 (2008).
   PubMed Web of Science ®Google Scholar
• Nemunaitis J , EdelmanJ. Selectively replicating viral vectors. Cancer Gene Ther.9(12), 987–1000 (2002).
   PubMed Web of Science ®Google Scholar
• Wilson JM . Gendicine. The first commercial gene therapy product. Hum. Gene Ther.16(9), 1014–1015 (2005).
   PubMed Web of Science ®Google Scholar
• Olins DE , OlinsAL, Von Hippel PH. Model nucleoprotein complexes: studies on the interaction of cationic homopolypeptides with DNA 501. J. Mol. Biol.24, 157–176 (1967).
   PubMed Web of Science ®Google Scholar
• Olins DE , OlinsAL, Von Hippel PH. On the structure and stability of DNA–protamine and DNA–polypeptide complexes. J. Mol. Biol.33, 265–281 (1968).
   PubMed Web of Science ®Google Scholar
• Shapiro JT , LengM, FelsenfeldG. Desoxyribonucleic acid–polylysine complexes. Structure and nucleotide specifity. Biochemistry8, 3219–3232 (1969).
   PubMed Web of Science ®Google Scholar
• Felgner PL , GadekTR, HolmMet al. Lipofection. A highly efficient, lipid mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA 84, 7413–7417 (1987).
   PubMed Web of Science ®Google Scholar
• Konstan MW , WagenerJS, HilliardKAet al. Single dose escalation study to evaluate safety of nasal administration of CFTR001 gene transfer vector to subjects with cystic fibrosis. Mol. Ther. 7, S386 (2003).
   PubMed Web of Science ®Google Scholar
• Hyde SC , PringleIA, AbdullahSet al. Cpg-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol. 26(5), 549–551 (2008).
   PubMed Web of Science ®Google Scholar
• Sidi AA , OhanaP, BenjaminSet al. Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to Bacillus Calmette–Guerin. J. Urol. 180(6), 2379–2383 (2008).
   PubMed Web of Science ®Google Scholar
• Wang J , SuiM, FanW. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr. Drug. Metab.11(2), 129–41 (2010).
   PubMed Web of Science ®Google Scholar
• Torchilin VP . Passive and active drug targeting. Drug delivery to tumors as an example. Handb. Exp. Pharmacol.(197), 3–53 (2010).
   PubMedGoogle Scholar
• Yotsumoto F , SanuiA, FukamiTet al. Efficacy of ligand-based targeting for the egf system in cancer. Anticancer Res. 29(11), 4879–4885 (2009).
   PubMed Web of Science ®Google Scholar
• Driessen WH , OzawaMG, ArapW, PasqualiniR. Ligand-directed cancer gene therapy to angiogenic vasculature. Adv. Genet.67, 103–121 (2009).
   PubMed Web of Science ®Google Scholar
• Gunther M , WagnerE, OgrisM. Specific targets in tumor tissue for the delivery of therapeutic genes. Curr. Med. Chem. Anticancer Agents5(2), 157–171 (2005).
   PubMedGoogle Scholar
• Pradhan P , BanerjeeR, BahadurD, KochC, MykhaylykO, PlankC. Targeted magnetic liposomes loaded with doxorubicin. Methods Mol. Biol.605, 279–293 (2010).
   PubMedGoogle Scholar
• Tashjian JA , DewhirstMW, NeedhamD, VigliantiBL. Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques. Int. J. Hyperthermia24(1), 79–90 (2008).
   PubMed Web of Science ®Google Scholar
• Li L , Ten Hagen TL, Schipper D et al. Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. J. Control. Release143(2), 274–279 (2010).
   PubMed Web of Science ®Google Scholar
• Mackay JA , ChilkotiA. Temperature sensitive peptides. Engineering hyperthermia-directed therapeutics. Int. J. Hyperthermia24(6), 483–495 (2008).
   PubMed Web of Science ®Google Scholar
• Bartlett DW , SuH, HildebrandtIJ, WeberWA, DavisME. Impact of tumor-specific targeting on the biodistribution and efficacy of sirna nanoparticles measured by multimodality in vivo imaging. Proc. Natl Acad. Sci. USA104(39), 15549–15554 (2007).
   PubMed Web of Science ®Google Scholar
• Philipp A , MeyerM, WagnerE. Extracellular targeting of synthetic therapeutic nucleic acid formulations. Curr. Gene Ther.8(5), 324–334 (2008).
   PubMed Web of Science ®Google Scholar
• Xenariou S , GriesenbachU, FerrariSet al. Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther. 13(21), 1545–1552 (2006).
   PubMed Web of Science ®Google Scholar
• Berg K , FoliniM, PrasmickaiteLet al. Photochemical internalization: a new tool for drug delivery. Curr. Pharm. Biotechnol. 8(6), 362–372 (2007).
   PubMed Web of Science ®Google Scholar
• Falk MH , IsselsRD. Hyperthermia in oncology. Int. J. Hyperthermia17(1), 1–18 (2001).
   PubMed Web of Science ®Google Scholar
• Wust P , HildebrandtB, SreenivasaGet al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 3(8), 487–497 (2002).
   PubMed Web of Science ®Google Scholar
• Karino T , KogaS, MaetaM. Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors. Jpn. J. Surg.18(3), 276–283 (1988).
   PubMedGoogle Scholar
• Song CW , ParkHJ, LeeCK, GriffinR. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int. J. Hyperthermia21(8), 761–767 (2005).
   PubMed Web of Science ®Google Scholar
• Hauck ML , DewhirstMW, BignerDD, ZalutskyMR. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model. Clin. Cancer Res.3(1), 63–70 (1997).
   PubMed Web of Science ®Google Scholar
• Kong G , BraunRD, DewhirstMW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res.60(16), 4440–4445 (2000).
   PubMed Web of Science ®Google Scholar
• Kong G , DewhirstMW. Hyperthermia and liposomes. Int. J. Hyperthermia15(5), 345–370 (1999).
   PubMed Web of Science ®Google Scholar
• Issels RD , SchlemmerM, LindnerLH. The role of hyperthermia in combined treatment in the management of soft tissue sarcoma. Curr. Oncol. Rep.8(4), 305–309 (2006).
   PubMedGoogle Scholar
• Chang E , ChalikondaS, FriedlJet al. Targeting vaccinia to solid tumors with local hyperthermia. Hum. Gene Ther. 16(4), 435–444 (2005).
   PubMed Web of Science ®Google Scholar
• Vekris A , MaurangeC, MoonenCet al. Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter. J. Gene Med. 2(2), 89–96 (2000).
   PubMed Web of Science ®Google Scholar
• Madio DP , Van Gelderen P, Despres D et al. On the feasibility of MRI-guided focused ultrasound for local induction of gene expression. J. Magn. Reson. Imaging8(1), 101–104 (1998).
   PubMed Web of Science ®Google Scholar
• Hoekstra D , RejmanJ, WasunguL, ShiF, ZuhornI. Gene delivery by cationic lipids: in and out of an endosome. Biochem. Soc. Trans.35(1), 68–71 (2007).
   PubMedGoogle Scholar
• Behr JP . The proton sponge: a trick to enter cells the viruses did not exploit. Chimia51(1–2), 34–36 (1997).
   Web of Science ®Google Scholar
• Cho YW , KimJD, ParkK. Polycation gene delivery systems: escape from endosomes to cytosol. J. Pharm. Pharmacol.55(6), 721–734 (2003).
   PubMed Web of Science ®Google Scholar
• Ogris M , BrunnerS, SchullerS, KircheisR, WagnerE. Pegylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther.6(4), 595–605 (1999).
   PubMed Web of Science ®Google Scholar
• Wightman L , KircheisR, RosslerVet al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3(4), 362–372 (2001).
   PubMed Web of Science ®Google Scholar
• Boussif O , Lezoualc‘hF, ZantaMAet al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad. Sci. USA 92(16), 7297–7301 (1995).
   PubMed Web of Science ®Google Scholar
• Kircheis R , KichlerA, WallnerGet al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4(5), 409–418 (1997).
   PubMed Web of Science ®Google Scholar
• Goula D , BenoistC, ManteroS, MerloG, LeviG, DemeneixBA. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther.5(9), 1291–1295 (1998).
   PubMed Web of Science ®Google Scholar
• Finsinger D , RemyJS, ErbacherP, KochC, PlankC. Protective copolymers for nonviral gene vectors. Synthesis, vector characterization and application in gene delivery. Gene Ther.7(14), 1183–1192 (2000).
   PubMed Web of Science ®Google Scholar
• Clamme JP , AzoulayJ, MelyY. Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys. J.84(3), 1960–1968 (2003).
   PubMed Web of Science ®Google Scholar
• Boeckle S , von Gersdorff K, van der Piepen S, Culmsee C, Wagner E, Ogris M. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J. Gene Med.6(10), 1102–1111 (2004).
   PubMed Web of Science ®Google Scholar
• Chollet P , FavrotMC, HurbinA, CollJL. Side-effects of a systemic injection of linear polyethylenimine–DNA complexes. J. Gene Med.4(1), 84–91 (2002).
   PubMed Web of Science ®Google Scholar
• Ogris M . Nucleic acid based therapeutics for tumor therapy. Anticancer Agents Med. Chem.6(6), 563–570 (2006).
   PubMedGoogle Scholar
• Fahrmeir J , GuntherM, TietzeN, WagnerE, OgrisM. Electrophoretic purification of tumor-targeted polyethylenimine-based polyplexes reduces toxic side effects in vivo. J. Control. Release122, 236–245 (2007).
   PubMed Web of Science ®Google Scholar
• Fischer D , BieberT, LiY, ElsasserHP, KisselT. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res.16(8), 1273–1279 (1999).
   PubMed Web of Science ®Google Scholar
• Pack DW , HoffmanAS, PunS, StaytonPS. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov.4(7), 581–593 (2005).
   PubMed Web of Science ®Google Scholar
• Kloeckner J , WagnerE, OgrisM. Degradable gene carriers based on oligomerized polyamines. Eur. J. Pharm. Sci.29(5), 414–425 (2006).
   PubMed Web of Science ®Google Scholar
• Russ V , ElfbergH, ThomaC, KloecknerJ, OgrisM, WagnerE. Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer. Gene Ther.15(1), 18–29 (2008).
   PubMed Web of Science ®Google Scholar
• Russ V , GuntherM, HalamaA, OgrisM, WagnerE. Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. J. Control. Release132(2), 131–140 (2008).
   PubMed Web of Science ®Google Scholar
• Klutz K , RussV, WillhauckMJet al. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene. Clin. Cancer Res. 15(19), 6079–6086 (2009).
   PubMed Web of Science ®Google Scholar
• Schwerdt A , ZintchenkoA, ConciaMet al. Hyperthermia induced targeting of thermosensitive gene carriers to tumors. Hum. Gene Ther. 19(11), 1283–1292 (2008).
   PubMed Web of Science ®Google Scholar
• Zintchenko A , OgrisM, WagnerE. Temperature dependent gene expression induced by PNIPAM-based copolymers: potential of hyperthermia in gene transfer. Bioconjug. Chem.17(3), 766–772 (2006).
   PubMed Web of Science ®Google Scholar
• Dreher MR , SimnickAJ, FischerKet al. Temperature triggered self-assembly of polypeptides into multivalent spherical micelles. J. Am. Chem. Soc. 130(2), 687–694 (2008).
   PubMed Web of Science ®Google Scholar
• Shir A , OgrisM, WagnerE, LevitzkiA. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice. PLoS Med.3(1), e6 (2006).
   PubMed Web of Science ®Google Scholar
• Takeda K , AkiraS. Toll-like receptors. Curr. Protoc. Immunol. Chapter 14, Unit 14.12 (2007).
   PubMedGoogle Scholar
• Salazar AM , LevyHB, OndraSet al. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic–polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery 38(6), 1096–1103; discussion 1103–1094 (1996).
   PubMed Web of Science ®Google Scholar
• Nakamura O , ShitaraN, MatsutaniM, TakakuraK, MachidaH. Phase I–II trials of poly(ICLC) in malignant brain tumor patients. J. Interferon Res.2(1), 1–4 (1982).
   PubMedGoogle Scholar
• Butowski N , LambornKR, LeeBLet al. A North American brain tumor consortium Phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas. J. Neurooncol. 91(2), 183–189 (2009).
   PubMed Web of Science ®Google Scholar
• Riesco-Eizaguirre G , SantistebanP. A perspective view of sodium iodide symporter research and its clinical implications. Eur. J. Endocrinol.155(4), 495–512 (2006).
   PubMed Web of Science ®Google Scholar
• Smanik PA , LiuQ, FurmingerTLet al. Cloning of the human sodium lodide symporter. Biochem. Biophys. Res. Commun. 226(2), 339–345 (1996).
   PubMed Web of Science ®Google Scholar
• Spitzweg C , MorrisJC. Approaches to gene therapy with sodium/iodide symporter. Exp. Clin. Endocrinol. Diabetes109(1), 56–59 (2001).
   PubMed Web of Science ®Google Scholar
• Barton KN , StrickerH, Brown Sl et al. Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. Mol. Ther.16(10), 1761–1769 (2008).
   PubMed Web of Science ®Google Scholar
• Kircheis R , SchullerS, BrunnerSet al. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med. 1(2), 111–120 (1999).
   PubMed Web of Science ®Google Scholar
• Klutz K , RussV, WillhauckMet al. Comparison of two different non-viral gene delivery vectors for systemic sodium iodide symporter gene transfer in HCC. Hum. Gene Ther. 20(11), 1515–1515 (2009).
   Web of Science ®Google Scholar
• Roth JA (Ed.). Gene-Based Therapies For Cancer. Springer, Heidelberg, Germany (2010).
   Google Scholar
• Freytag SO , KhilM, StrickerHet al. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res. 62(17), 4968–4976 (2002).
   PubMed Web of Science ®Google Scholar
• Weichselbaum RR , KufeD. Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers. Cancer Gene Ther.16(8), 609–619 (2009).
   PubMed Web of Science ®Google Scholar
• Davis ME . The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharm.6(3), 659–668 (2009).
   PubMed Web of Science ®Google Scholar
• Davis ME , ZuckermanJE, ChoiCHet al. Evidence of RNAi in humans from systemically administered sirna via targeted nanoparticles. Nature 464(7291), 1067–1070 (2010).
   PubMed Web of Science ®Google Scholar
• Mayrhofer P , SchleefM, JechlingerW. Use of minicircle plasmids for gene therapy. Methods Mol. Biol.542, 87–104 (2009).
   PubMedGoogle Scholar
• Klein-Marcuschamer D , YadavVG, GhaderiA, StephanopoulosGN. De novo metabolic engineering and the promise of synthetic DNA. Adv. Biochem. Eng. Biotechnol. (2010) (Epub ahead of print).
   PubMedGoogle Scholar

Websites

• Challenges in the process development of a novel Zero-CpG CFTR plasmid for human clinical use www.users.ox.ac.uk/∼genemed/Publications/pdf/HebelASGT08.pdf
   Google Scholar
• Glucocorticoid modulation of nucleic acid-mediated immune stimulation www.freepatentsonline.com/20070054873.pdf
   Google Scholar
• Clinicaltrials.gov – study NCT00393809 www.clinicaltrials.gov/ct2/show/NCT00393809
   Google Scholar
• Clinicaltrials.gov – study NCT00788307 www.clinicaltrials.gov/ct2/show/NCT00788307
   Google Scholar